# FDA 483 - The Procter & Gamble Manufacturing Company - March 10, 2017

Source: https://www.globalkeysolutions.net/records/483/the-procter-gamble-manufacturing-company/8389c2d9-66f8-4d98-bab2-b06f4a66107f

> FDA 483 for The Procter & Gamble Manufacturing Company on March 10, 2017. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: The Procter & Gamble Manufacturing Company
- Inspection Date: 2017-03-10
- Product Type: drugs
- Office Name: Atlanta District Office
- Summary: During an inspection of Procter & Gamble Manufacturing Co in Browns Summit, NC, the FDA observed issues with laboratory recordkeeping. Specifically, a second person verifier signed off on testing logbooks without adequately authenticating the accuracy of the results or recorded information. This indicates a lapse in quality control procedures for laboratory data.

## Related Documents

- [483 - 2022-02-18](https://www.globalkeysolutions.net/records/483/the-procter-gamble-manufacturing-company/65e947f7-42f1-4683-ae69-237a395bcc6f)

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/daveta-l-bailey/b3c06872-638b-4c47-9539-a93b819be23f)
- [Kara Dobbin](https://www.globalkeysolutions.net/people/kara-dobbin/0b35e025-4389-46df-abcb-30e70693f62b)

Company: https://www.globalkeysolutions.net/companies/the-procter-gamble-manufacturing-company/bdbd5ab4-9fbf-474f-bcfb-fd22714dcbc8

Office: https://www.globalkeysolutions.net/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7